CORCEPT THERAPEUTICS INC

CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001088856

Price chart

Open-market purchases and sales by CORT insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 18, 20267:53 PM ETSep 16, 2026Vieira Roberto WandenkolkPresident, OncologySSaleCommon Stock−296$100.82−$29.84K3.95K−7.0%SEC10b5-1
Sep 16, 20264:30 PM ETSep 14, 2026Lyon Joseph DouglasSee RemarksSSaleCommon Stock−10K$113.4947−$1.13M5.68K−63.8%SEC10b5-1
Sep 16, 20264:30 PM ETSep 15, 2026WILSON JAMES NDirectorSSaleCommon Stock−10K$110.694−$1.11M1.06M−0.9%SEC10b5-1
Sep 3, 20269:16 PM ETSep 1, 2026Maduck SeanSee RemarksSSaleCommon Stock−25K$114.4295−$2.86M9.76K−71.9%SEC10b5-1
Sep 3, 20269:02 PM ETSep 2, 2026Vieira Roberto WandenkolkPresident, OncologySSaleCommon Stock−58.33K$110.7566−$6.46M4.24K−93.2%SEC10b5-1

The largest institutional positions in CORT at the end of Q2 2026.

Institutions holding CORT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.12,432,023$1.08B0.02%+280,747+2.3%Added
INGALLS & SNYDER LLC7,934,507$689.91M18.85%+325,791+4.3%Added
RENAISSANCE TECHNOLOGIES LLC5,261,628$457.5M0.63%−421,155−7.4%Reduced
VANGUARD PORTFOLIO MANAGEMENT LLC5,044,638$438.63M0.02%+224,070+4.6%Added
VANGUARD CAPITAL MANAGEMENT LLC4,172,482$362.8M0.01%+95,286+2.3%Added